Barlas, S. (2015). FDA Advisory Committee Approval of First Biosimilar Leaves Questions Unanswered: Sandoz’s Filgrastim Faces Naming and Court Hurdles. P T.
Citação norma ChicagoBarlas, Stephen. "FDA Advisory Committee Approval of First Biosimilar Leaves Questions Unanswered: Sandoz’s Filgrastim Faces Naming and Court Hurdles." P T 2015.
MLA引文Barlas, Stephen. "FDA Advisory Committee Approval of First Biosimilar Leaves Questions Unanswered: Sandoz’s Filgrastim Faces Naming and Court Hurdles." P T 2015.
警告:這些引文格式不一定是100%准確.